Clarametyx Biosciences has received approval from the Independent DMC to progress its Phase Ib/IIa trial of CMTX-101 ...

Clarametyx is advancing a Phase 1b/2a clinical trial of CMTX-101 for cystic fibrosis (CF)-associated infections following an interim analysis.

One of the study’s most consistent findings is the systemic failure of the Greek educational system to nurture critical ...

With the approval of canton authorities, the geothermal project in Haute-Sorne in Jura, Switzerland will proceed with ...

PanOmiQ™ Research sets a new global benchmark for precision health innovation.

The study shows that GAIL has a direct and significant impact on job performance. This link is not merely technological, it ...

After 3 months of follow-up, patients randomized to geriatric assessment-guided intervention (GAIN-S) had significantly ...

Over 37% of US adults experience moderate-to-severe loneliness, with a higher prevalence among specific sociodemographic ...

Independence Gold Corp. (TSXV: IGO) (OTCQB: IEGCF) ("Independence" or "the Company") is pleased to report the successful completion of its 2024-2025 drill program at the 3Ts Project. Located ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...